{"id":544651,"date":"2010-04-27T12:18:53","date_gmt":"2010-04-27T16:18:53","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=76069"},"modified":"2010-04-27T12:18:53","modified_gmt":"2010-04-27T16:18:53","slug":"fda-gives-digirad-ok-to-market-ergo-device","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/544651","title":{"rendered":"FDA Gives Digirad OK to Market Ergo Device"},"content":{"rendered":"\n
Life Sciences<\/a>, Medical imaging<\/a>, FDA<\/a><\/div>\n

\t\tBruce V. Bigelow wrote:<\/strong><\/p>\n

Digirad (NASDAQ: DRAD<\/a>), a medical imaging company based in Poway, CA, says it got regulatory approval to market Ergo, a new nuclear imaging camera system for hospitals. Digirad CEO Todd Clyde tells the San Diego Union-Tribune<\/a> that what sets the solid-state camera apart is its field of view and its portability, which means patients won’t have to be wheeled from their hospital rooms to get scanned.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

UNDERWRITERS AND PARTNERS
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t<\/p>\n

\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t\t\t

\n

\n\"\"<\/a>
\n\"\"<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Life Sciences, Medical imaging, FDA Bruce V. Bigelow wrote: Digirad (NASDAQ: DRAD), a medical imaging company based in Poway, CA, says it got regulatory approval to market Ergo, a new nuclear imaging camera system for hospitals. Digirad CEO Todd Clyde tells the San Diego Union-Tribune that what sets the solid-state camera apart is its field […]<\/p>\n","protected":false},"author":5423,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-544651","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/544651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/5423"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=544651"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/544651\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=544651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=544651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=544651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}